Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immunoprecise Antibodies Ltd (IPA)

Immunoprecise Antibodies Ltd (IPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 95,539
  • Shares Outstanding, K 46,154
  • Annual Sales, $ 17,590 K
  • Annual Income, $ -21,690 K
  • EBIT $ -7 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.53
  • Price/Sales 5.06
  • Price/Cash Flow N/A
  • Price/Book 5.64
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.28
  • Most Recent Earnings $-0.04 on 07/29/25
  • Next Earnings Date 09/15/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Information Systems

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 07/31/25
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +63.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.64 +26.22%
on 08/04/25
3.25 -36.23%
on 08/25/25
+0.43 (+26.22%)
since 08/01/25
3-Month
0.50 +314.00%
on 06/04/25
3.25 -36.23%
on 08/25/25
+1.51 (+267.35%)
since 06/03/25
52-Week
0.27 +666.67%
on 03/04/25
3.25 -36.23%
on 08/25/25
+1.35 (+187.62%)
since 09/03/24

Most Recent Stories

More News
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

An Evolution in Name, Structure, and Strategy Reflecting the Company’s AI-Driven Platform and Bio-Native Discovery Vision

IPA : 2.07 (+7.25%)
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 27th Annual Global Investment Conference in New York

ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), today announced that it will participate in the 27th Annual H.C. Wainwright Global Investment Conference, taking place...

IPA : 2.07 (+7.25%)
ImmunoPrecise Advances AI Discovered and Developed Universal Dengue Vaccine Initiative: Moves into Preclinical Antibody Generation

Manufacturing of validated dengue epitope underway; proprietary immunization studies in rabbit model to assess monoclonal antibody (mAb) responses.

IPA : 2.07 (+7.25%)
This Penny Stock Has Wall Street's Attention and Is Up Nearly 600%

ImmunoPrecise Antibodies (IPA) shows strong technical momentum, hitting new 52-week highs on Aug. 21. The stock maintains a 100% “Buy” opinion from Barchart. Shares are up an impressive 565% in 2025....

IPA : 2.07 (+7.25%)
ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug discovery, today announced the successful sale...

IPA : 2.07 (+7.25%)
ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA

ImmunoPrecise Antibodies Ltd. (“IPA”, “Company”, “we” or “us”) (NASDAQ: IPA), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today...

IPA : 2.07 (+7.25%)
ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a Bio-Native AI pioneer operating where TechBio meets true biological intelligence, today announced results of a newly expanded...

IPA : 2.07 (+7.25%)
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced the appointment...

IPA : 2.07 (+7.25%)
IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2025 on July 29, 2025

The Company to host an earnings conference call via webcast

IPA : 2.07 (+7.25%)
IPA to Present at The Microcap Conference 2025

VICTORIA, BC / ACCESSWIRE / December 19, 2024 / IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced is...

IPA : 2.07 (+7.25%)

Business Summary

ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA.

See More

Key Turning Points

3rd Resistance Point 2.44
2nd Resistance Point 2.34
1st Resistance Point 2.20
Last Price 2.07
1st Support Level 1.97
2nd Support Level 1.87
3rd Support Level 1.73

See More

52-Week High 3.25
Fibonacci 61.8% 2.11
Last Price 2.07
Fibonacci 50% 1.76
Fibonacci 38.2% 1.41
52-Week Low 0.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar